论文部分内容阅读
目的探讨丙泊酚复合舒芬太尼实施无痛人流的可行性与安全性。方法将100例人流产患者随机分为观察组和对比组。观察和记录两组患者术前、术中、术后的MAP、HR、RR、Sp技术指标,术中是否有体动反应,术后患者舒适度及满意度。结果舒芬太尼组较芬太尼组术中体动反应减少(P<0.05)。观察组和对比组手术中血流动力学变化及满意度比较差异无统计学意义(P>0.05)。结论丙泊酚复合舒芬太尼用于无痛人流,镇痛效果确切血流动力学相对平稳,术中体动反应发生率明显减少,术后宫缩痛镇痛效果十分明显表明该方法舒适安全、可行值得推广。
Objective To investigate the feasibility and safety of propofol combined with sufentanil in painless abortion. Methods 100 cases of abortion patients were randomly divided into observation group and control group. Observed and recorded preoperative, intraoperative and postoperative MAP, HR, RR, Sp technical indicators, whether there is intraoperative physical activity, postoperative comfort and satisfaction. Results Compared with the fentanyl group, the sufentanil group had less physical activity during operation (P <0.05). There was no significant difference in hemodynamics and satisfaction among observation group and control group (P> 0.05). Conclusion Propofol combined with sufentanil for painless flow, the exact analgesic hemodynamics is relatively stable, the incidence of postoperative motor response was significantly reduced, postoperative analgesic effect of uterine contraction is very clear that the method is comfortable Safe and feasible worth promoting.